BACKGROUND Bevacizumab is an antiangiogenic agent,and that synergizes with chemotherapeutic drugs.When used in combination therapies,Bevacizumab is associated w
Every day,investigators find a new link between a form of cancer and a particular alteration in the sequence or/and expression level of a key gene,awarding this